Acadian Asset Management
APLT

Acadian Asset Management’s Applied Therapeutics APLT Stock Holding History

Acadian Asset Management’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,434
Closed -$29K – 1623
2024
Q3 		$29K Buy
+3,434
New +$20.2K ﹤0.01% 1917
2024
Q1 		– Sell
-13,689
Closed -$45K – 1558
2023
Q4 		$45K Buy
+13,689
New +$34.1K ﹤0.01% 1472
2023
Q2 		– Sell
-47,495
Closed -$38K – 1716
2023
Q1 		$38K Sell
47,495
-39,900
-46% -$39.3K ﹤0.01% 1555
2022
Q4 		$65K Hold
87,395
– – ﹤0.01% 1521
2022
Q3 		$80K Buy
87,395
+40,563
+87% +$48.7K ﹤0.01% 1408
2022
Q2 		$45K Buy
46,832
+13,487
+40% +$22.1K ﹤0.01% 1507
2022
Q1 		$70K Buy
+33,345
New +$89.3K ﹤0.01% 1423

Other funds holding APLT

VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Acadian Asset Management's APLT Position: Q4 2024 in Review

Acadian Asset Management sold out of Applied Therapeutics (APLT) in Q4 2024, closing a stake of 3,434 shares — an estimated $29K sold.

Acadian Asset Management first reported a position in APLT in Q1 2022 and held it in 7 quarters. The position peaked at $80K in Q3 2022. 119 funds tracked by Wall St. Rank hold APLT as of Q4 2024.

  • Acadian Asset Management reported no remaining Applied Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Acadian Asset Management sold 3,434 Applied Therapeutics shares in Q4 2024, an estimated $29K.
  • Acadian Asset Management first reported a position in Applied Therapeutics in Q1 2022 and held it in 7 quarters.
  • Acadian Asset Management's Applied Therapeutics position peaked at $80K in Q3 2022.
  • 119 funds tracked by Wall St. Rank held Applied Therapeutics as of Q4 2024.

Based on Acadian Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.